BridgeBio Pharma Inc (BBIO)
30.10
-0.94
(-3.04%)
USD |
NASDAQ |
May 17, 16:00
30.10
0.00 (0.00%)
After-Hours: 20:00
BridgeBio Pharma Total Liabilities (Quarterly): 1.886B for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 1.886B |
December 31, 2023 | 1.889B |
September 30, 2023 | 1.849B |
June 30, 2023 | 1.853B |
March 31, 2023 | 1.839B |
December 31, 2022 | 1.868B |
September 30, 2022 | 1.859B |
June 30, 2022 | 1.877B |
March 31, 2022 | 1.854B |
December 31, 2021 | 1.878B |
September 30, 2021 | 1.517B |
Date | Value |
---|---|
June 30, 2021 | 1.537B |
March 31, 2021 | 1.481B |
December 31, 2020 | 595.70M |
September 30, 2020 | 569.31M |
June 30, 2020 | 577.72M |
March 31, 2020 | 537.73M |
December 31, 2019 | 155.70M |
September 30, 2019 | 116.26M |
June 30, 2019 | 593.09M |
March 31, 2019 | 90.71M |
December 31, 2018 | 87.58M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
116.26M
Minimum
Sep 2019
1.889B
Maximum
Dec 2023
1.317B
Average
1.688B
Median
Total Liabilities (Quarterly) Benchmarks
Pfizer Inc | 128.54B |
Alnylam Pharmaceuticals Inc | 4.044B |
Regenxbio Inc | 238.55M |
ACADIA Pharmaceuticals Inc | 391.06M |
Biomarin Pharmaceutical Inc | 1.799B |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 849.33M |
Shareholders Equity (Quarterly) | -1.050B |
Debt to Equity Ratio | -1.635 |
Current Ratio | 5.538 |
Net Debt Paydown Yield | -0.03% |